Agilent is a global leader in life science, diagnostics, and analytical laboratory technologies. Now growing in the cell analysis space, Agilent instruments, software, services, solutions, and people provide trusted answers to our customers' most challenging questions.
What started as a unique offering of solutions focused on understanding cellular functionality based on underlying metabolic programming has transformed into a set of innovative tools with the additions of ACEA Biosciences and BioTek Instruments – providing customers the tools they need to uncover unique cell biology, discover novel drug targets, improve preclinical in vitro toxicology, and pioneer the next generation of immunotherapies.
Explore a breadth of solutions in real-time, impedance-based analysis of cell function, real-time cell metabolism, cell imaging and microscopy, microplate readers, microplate washers, flow cytometers, and more.
For Research Use Only. Not for use in diagnostic procedures.
Accelerate Your Drug Discoveries with Live Cell Analysis
As the cost of bringing new drugs to market continues to grow, so do the pressures around increasing efficiency and productivity throughout the discovery and development cycle. And, no matter the stage, cell based analysis plays a critical role whether that be in discovery stages where you're identifying new potential targets, in screening where you're modifying the target, or in toxicity studies where you're examining adverse effects on targets.
Join us for our two-day Agilent Cell Analysis Drug Discovery and Development live conference. Agilent, and BioTek, the newest member of the Agilent family, will be showcasing their latest innovations in cell analysis for drug discovery research including interactive booths, scientific posters and live chat with product experts. There will also be a series of presentations from industry leaders who will discuss how they’ve adopted cell-based assays in their work to increase efficiency and productivity across:
Discover how leading researchers worldwide are conducting novel research in drug discovery and development, and how Agilent provides key technologies and solutions to advance their therapeutic opportunities through the different stages of drug development:
For Research Use Only. Not for use in diagnostic procedures.
Staff Scientist, Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Associate Professor of Biophysics, University of Bath; Director, BLOC Laboratories Ltd
Co Founder, CSO at SyntheX, Inc.
Associate Dean for Research, Endowed Professor in Mitochondrial Medicine and Pathology, University of Alabama at Birmingham
Senior Scientist, Immunotherapy, Pre-clinical Development, Elevatebio
Principal Scientist, Gilead Sciences, Inc.